| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Picard Medical, Inc.: Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026 | 1 | GlobeNewswire (USA) | ||
| 27.07. | Picard Medical, Inc.: Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026 | 2 | GlobeNewswire (USA) | ||
| PICARD MEDICAL Aktie jetzt für 0€ handeln | |||||
| 27.07. | Picard Medical regains NYSE compliance | 2 | Seeking Alpha | ||
| 27.07. | Picard Medical regains compliance with NYSE American listing | 1 | Investing.com | ||
| 27.07. | Picard Medical, Inc.: Picard Medical Receives NYSE American Acceptance of Compliance Plan | 222 | GlobeNewswire (Europe) | TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first... ► Artikel lesen | |
| 22.07. | Picard Medical announces 1-for-50 reverse stock split to maintain NYSE American listing; stock slips | 3 | Seeking Alpha | ||
| 22.07. | Picard Medical approves 1-for-50 reverse stock split | 4 | Investing.com | ||
| 22.07. | Picard Medical, Inc.: Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance | 209 | GlobeNewswire (Europe) | -Reverse stock split to support continued compliance with NYSE American continued listing standards- TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the... ► Artikel lesen | |
| 21.07. | Picard Medical, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 15.07. | Picard Medical's artificial heart platform reviewed in journal | 2 | Investing.com | ||
| 15.07. | Fachzeitschrift beleuchtet Plattform für künstliches Herz von Picard Medical | 2 | Investing.com Deutsch | ||
| 15.07. | Picard Medical, Inc.: Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program | 126 | GlobeNewswire (Europe) | TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen | |
| 13.07. | Picard Medical, Inc.: Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting | 3 | GlobeNewswire (USA) | ||
| 02.07. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 02.07. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 02.07. | Picard Medical, Inc.: Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting | 1 | GlobeNewswire (USA) | ||
| 24.06. | Picard Medical CEO Patrick NJ Schnegelsberg to depart | 1 | MassDevice | ||
| 24.06. | Picard Medical CEO steps down, board names interim replacement | 2 | Investing.com | ||
| 24.06. | Picard Medical, Inc.: Picard Medical Announces Leadership Transition | 264 | GlobeNewswire (Europe) | TUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen | |
| 24.06. | Picard Medical, Inc. - 8-K, Current Report | 3 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 27,020 | -3,08 % | Hims & Hers-Aktie: Folgt der nächste Wachstumsturbo? | Die Aktie von Hims & Hers Health hat sich in den vergangenen Jahren zu einem der spektakulärsten Wachstumswerte im Gesundheitssektor entwickelt. Die operativen Kennzahlen sprechen weiterhin für erhebliches... ► Artikel lesen | |
| CERENOME | 3,450 | 0,00 % | Plus Therapeutics Inc.: Cerenome Launches as an Integrated CNS Oncology Company | HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), today announces that its corporate rebrand to Cerenome will be completed as scheduled. Effective... ► Artikel lesen | |
| ORGANON | 11,725 | -0,26 % | Organon: $81 Million Jada Gain Lifts GAAP Profit 68% As Adjusted Earnings Fall 29% | ||
| QUIDELORTHO | 15,355 | +0,75 % | QuidelOrtho Corporation: QuidelOrtho Appoints Micah Young as Chief Financial Officer | Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:... ► Artikel lesen | |
| NANO-X IMAGING | 1,005 | -6,07 % | Nano-X Imaging Q2 2026 Earnings Preview | ||
| ROCKWELL MEDICAL | 7,300 | -3,57 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| NUWELLIS, INC | 1,695 | -9,84 % | Morning Market Movers: Nuwellis, T3 Defense, Capricor Therapeutics, PN Smart Energy See Big Swings | DEERFIELD (dpa-AFX) - At 8:45 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,010 | +3,99 % | Jefferies senkt Kursziel für Procept BioRobotics nach verfehlten Eingriffszahlen | ||
| NEURONETICS | 2,040 | +2,26 % | Neuronetics and Jorey Chernett Announce Shared Vision | ||
| PULSE BIOSCIENCES | 32,000 | -3,61 % | Biotech Stocks At 52-Week Highs - INCY Rises With Q2 Results, PLSE, SI, BVS, LBRX | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 28, 2026, driven by key catalysts including positive quarterly results.Incyte Corporation (INCY)Incyte is a... ► Artikel lesen | |
| OPTIMIZERX | 6,920 | +1,02 % | OptimizeRx Corporation: OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer | WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 1,420 | +42,00 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study | ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 10,300 | -0,96 % | Orthofix Medical beats top-line and bottom-line estimates; updates FY26 outlook | ||
| PAVMED | 4,190 | -8,62 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| OWLET | 5,540 | +3,75 % | Owlet Announces New $25 Million Credit Facility With Wells Fargo |